Kexing Biopharm — Investor Relations & Filings
Kexing Biopharm is an innovative biopharmaceutical enterprise engaged in the research, development, production, and sales of recombinant protein drugs and micro-ecological preparations. The company focuses on developing treatments for therapeutic areas including kidney diseases, oncology, antiviral therapy, autoimmune disorders, metabolic diseases, and degenerative diseases. A key product in its portfolio is Erythropoietin Injection. Kexing Biopharm maintains a comprehensive quality system that aligns with international standards, covering the entire drug lifecycle from production and quality control to release and transportation, ensuring the continuous and stable manufacturing of safe and effective medicines.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于参加2026年山东辖区上市公司投资者网上集体接待日活动的公告 | 2026-05-12 | Chinese | |
| 关于向香港联交所递交H股发行并上市申请的进展公告 | 2026-05-07 | Chinese | |
| 2025年度独立董事述职报告（何如意） | 2026-04-21 | Chinese | |
| 2025年度募集资金存放、管理与实际使用情况的专项报告 | 2026-04-21 | Chinese | |
| 2025年度审计报告 | 2026-04-21 | Chinese | |
| 北京市嘉源律师事务所关于科兴生物制药股份有限公司2024年限制性股票激励计划作废部分限制性股票事项的法律意见书 | 2026-04-21 | Chinese |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45347072 | 关于参加2026年山东辖区上市公司投资者网上集体接待日活动的公告 | 2026-05-12 | Chinese | ||
| 44265396 | 关于向香港联交所递交H股发行并上市申请的进展公告 | 2026-05-07 | Chinese | ||
| 44450779 | 2025年度独立董事述职报告（何如意） | 2026-04-21 | Chinese | ||
| 44450767 | 2025年度募集资金存放、管理与实际使用情况的专项报告 | 2026-04-21 | Chinese | ||
| 44450762 | 2025年度审计报告 | 2026-04-21 | Chinese | ||
| 44450564 | 北京市嘉源律师事务所关于科兴生物制药股份有限公司2024年限制性股票激励计划作废部分限制性股票事项的法律意见书 | 2026-04-21 | Chinese | ||
| 44450540 | 中信建投证券股份有限公司关于科兴生物制药股份有限公司2025年度募集资金存放、管理与实际使用情况的专项核查报告 | 2026-04-21 | Chinese | ||
| 44450504 | 2025年度内部控制评价报告 | 2026-04-21 | Chinese | ||
| 44450492 | 2025年度独立董事述职报告（曹红中-已离任） | 2026-04-21 | Chinese | ||
| 44450483 | 关于2025年度利润分配方案及2026年中期分红规划的公告 | 2026-04-21 | Chinese | ||
| 44450477 | 2025年度独立董事述职报告（张汉斌） | 2026-04-21 | Chinese | ||
| 44450469 | 自愿披露关于GB19注射液获得美国FDA新药临床试验许可的公告 | 2026-03-30 | Chinese | ||
| 44450457 | 关于开立募集资金专项账户并签订募集资金专户存储三方监管协议的公告 | 2026-03-20 | Chinese | ||
| 44450444 | 关于股份回购进展及实施结果暨股份变动的公告 | 2026-03-03 | Chinese | ||
| 44450432 | 自愿披露关于GB19注射液皮肤型红斑狼疮适应症获得药物临床试验批准通知书的公告 | 2026-03-03 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Kexing Biopharm via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17862/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17862 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17862 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17862 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17862}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Kexing Biopharm (id: 17862)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.